139 related articles for article (PubMed ID: 38335809)
1. Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein.
Semenyuk PI
Biophys Chem; 2024 Apr; 307():107196. PubMed ID: 38335809
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of amyloid fibril formed by α-synuclein hereditary A53E mutation reveals a distinct protofilament interface.
Sun C; Zhou K; DePaola P; Shin WS; Hillyer T; Sawaya MR; Zhu R; Peng C; Zhou ZH; Jiang L
J Biol Chem; 2023 Apr; 299(4):104566. PubMed ID: 36871760
[TBL] [Abstract][Full Text] [Related]
3. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
[TBL] [Abstract][Full Text] [Related]
4. The role of the acidic domain of α-synuclein in amyloid fibril formation: a molecular dynamics study.
Park S; Yoon J; Jang S; Lee K; Shin S
J Biomol Struct Dyn; 2016; 34(2):376-83. PubMed ID: 25869255
[TBL] [Abstract][Full Text] [Related]
5. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
[TBL] [Abstract][Full Text] [Related]
6. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
Atsmon-Raz Y; Miller Y
ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
[TBL] [Abstract][Full Text] [Related]
7. The fold preference and thermodynamic stability of α-synuclein fibrils is encoded in the non-amyloid-β component region.
Xu L; Bhattacharya S; Thompson D
Phys Chem Chem Phys; 2018 Feb; 20(6):4502-4512. PubMed ID: 29372732
[TBL] [Abstract][Full Text] [Related]
8. REMD Simulations of Full-Length Alpha-Synuclein Together with Ligands Reveal Binding Region and Effect on Amyloid Conversion.
Semenyuk PI
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232847
[TBL] [Abstract][Full Text] [Related]
9. Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy.
Li Y; Zhao C; Luo F; Liu Z; Gui X; Luo Z; Zhang X; Li D; Liu C; Li X
Cell Res; 2018 Sep; 28(9):897-903. PubMed ID: 30065316
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure.
Zhao K; Li Y; Liu Z; Long H; Zhao C; Luo F; Sun Y; Tao Y; Su XD; Li D; Li X; Liu C
Nat Commun; 2020 May; 11(1):2643. PubMed ID: 32457390
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
Kawahata I; Finkelstein DI; Fukunaga K
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
[TBL] [Abstract][Full Text] [Related]
12. Kinetic control in amyloid polymorphism: Different agitation and solution conditions promote distinct amyloid polymorphs of alpha-synuclein.
Devi S; Garg DK; Bhat R
Biochim Biophys Acta Proteins Proteom; 2023 Jul; 1871(4):140917. PubMed ID: 37061153
[TBL] [Abstract][Full Text] [Related]
13. Distinct Effects of Familial Parkinson's Disease-Associated Mutations on α-Synuclein Phase Separation and Amyloid Aggregation.
Xu B; Fan F; Liu Y; Liu Y; Zhou L; Yu H
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238596
[TBL] [Abstract][Full Text] [Related]
14. Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.
Zhao K; Lim YJ; Liu Z; Long H; Sun Y; Hu JJ; Zhao C; Tao Y; Zhang X; Li D; Li YM; Liu C
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20305-20315. PubMed ID: 32737160
[TBL] [Abstract][Full Text] [Related]
15. Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils.
Jana AK; Lander CW; Chesney AD; Hansmann UHE
J Phys Chem B; 2022 May; 126(20):3648-3658. PubMed ID: 35580331
[TBL] [Abstract][Full Text] [Related]
16. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
17. Comparative Analysis of the Relative Fragmentation Stabilities of Polymorphic Alpha-Synuclein Amyloid Fibrils.
Sanami S; Purton TJ; Smith DP; Tuite MF; Xue WF
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625557
[TBL] [Abstract][Full Text] [Related]
18. A Targetable N-Terminal Motif Orchestrates α-Synuclein Oligomer-to-Fibril Conversion.
Santos J; Cuellar J; Pallarès I; Byrd EJ; Lends A; Moro F; Abdul-Shukkoor MB; Pujols J; Velasco-Carneros L; Sobott F; Otzen DE; Calabrese AN; Muga A; Pedersen JS; Loquet A; Valpuesta JM; Radford SE; Ventura S
J Am Chem Soc; 2024 May; 146(18):12702-12711. PubMed ID: 38683963
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease.
Gracia P; Camino JD; Volpicelli-Daley L; Cremades N
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126694
[TBL] [Abstract][Full Text] [Related]
20. The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.
Boyer DR; Li B; Sun C; Fan W; Zhou K; Hughes MP; Sawaya MR; Jiang L; Eisenberg DS
Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3592-3602. PubMed ID: 32015135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
